doi: 10.1196/annals.1355.039.
Activity of telithromycin against thirteen new isolates of C. burnetii including three resistant to doxycycline
Affiliations
- PMID: 16481522
- DOI: 10.1196/annals.1355.039
Item in Clipboard
Activity of telithromycin against thirteen new isolates of C. burnetii including three resistant to doxycycline
Ann N Y Acad Sci.
2005 Dec.
Abstract
In this study we have evaluated the in vitro activity of antibiotics against 13 new isolates of Coxiella burnetii using a real-time quantitative PCR assay. MICs against doxycycline ranged from 1 to 8 microg/mL, telithromycin from 0.5 to 2 microg/mL, and all strains had MICs > or = 8 microg/mL for erythromycin. We report that strains resistant to doxycycline exist either in humans or animals.
Similar articles
-
In vitro susceptibility of Coxiella burnetii to linezolid in comparison with its susceptibilities to quinolones, doxycycline, and clarithromycin.Antimicrob Agents Chemother. 2001 Nov;45(11):3276-8. doi: 10.1128/AAC.45.11.3276-3278.2001. Antimicrob Agents Chemother. 2001. PMID: 11600400 Free PMC article.
-
Correlation between ratio of serum doxycycline concentration to MIC and rapid decline of antibody levels during treatment of Q fever endocarditis.Antimicrob Agents Chemother. 2005 Jul;49(7):2673-6. doi: 10.1128/AAC.49.7.2673-2676.2005. Antimicrob Agents Chemother. 2005. PMID: 15980335 Free PMC article.
-
Bacteriostatic and bactericidal activities of tigecycline against Coxiella burnetii and comparison with those of six other antibiotics.Antimicrob Agents Chemother. 2009 Jun;53(6):2690-2. doi: 10.1128/AAC.01424-08. Epub 2009 Mar 30. Antimicrob Agents Chemother. 2009. PMID: 19332671 Free PMC article.
-
[Drug activity against Coxiella burnetii, a pathogen of Q fever].Antibiot Khimioter. 2007;52(1-2):46-56. Antibiot Khimioter. 2007. PMID: 18461810 Review. Russian. No abstract available.
-
Treatment of Q fever.Antimicrob Agents Chemother. 1993 Sep;37(9):1733-6. doi: 10.1128/AAC.37.9.1733. Antimicrob Agents Chemother. 1993. PMID: 8239576 Free PMC article. Review. No abstract available.
Cited by
-
Q Fever: current state of knowledge and perspectives of research of a neglected zoonosis.Int J Microbiol. 2011;2011:248418. doi: 10.1155/2011/248418. Epub 2011 Dec 13. Int J Microbiol. 2011. PMID: 22194752 Free PMC article.
-
Finafloxacin, a Novel Fluoroquinolone, Reduces the Clinical Signs of Infection and Pathology in a Mouse Model of Q Fever.Front Microbiol. 2021 Nov 30;12:760698. doi: 10.3389/fmicb.2021.760698. eCollection 2021. Front Microbiol. 2021. PMID: 34917048 Free PMC article.
-
Efficacy of rifapentine and other rifamycins against Coxiella burnetii in vitro.Microbiol Spectr. 2024 Jul 2;12(7):e0103424. doi: 10.1128/spectrum.01034-24. Epub 2024 Jun 12. Microbiol Spectr. 2024. PMID: 38864598 Free PMC article.
-
Quantitative proteome profiling of C. burnetii under tetracycline stress conditions.PLoS One. 2012;7(3):e33599. doi: 10.1371/journal.pone.0033599. Epub 2012 Mar 16. PLoS One. 2012. PMID: 22438959 Free PMC article.
-
Coxiella burnetii Intratracheal Aerosol Infection Model in Mice, Guinea Pigs, and Nonhuman Primates.Infect Immun. 2019 Nov 18;87(12):e00178-19. doi: 10.1128/IAI.00178-19. Print 2019 Dec. Infect Immun. 2019. PMID: 31501249 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
